Smoking Cessation Aids

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definition and Scope of Study
• Smoking Cessation Aids
• Definitions
• A. Nicotine Gum
• B. Nicotine Patch
• C. Nicotine Lozenges And Tablets
• D. Others
• Nicotine Inhaler
• Nicotine Nasal Spray

II. EXECUTIVE SUMMARY

1. Industry Outlook

• Leading Players
• Tobacco Products Industry: An Introduction
• Regulations/Taxes
• Black Market
• Cigarette: The" Tobacco King
• Cigars: All Rolled Up
• Glut of Products Restrain Growth
• Major Cigar Tobacco Producing Regions
• China Dominates the Cigarettes Sector
• Competitive Scenario
• Table 1: World Cigarettes Market for 2004 & 2005: Market Shares Based on Volume Sales of Leading Manufacturers for Philip Morris, British American Tobacco, Japan Tobacco, Imperial Tobacco, Gallaher, Reynolds American and Others (includes corresponding Graph/Chart)
• Table 2: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Billion Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)
• Table 3: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)
• Table 4: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)
• Table 5: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)
• Why to Quit Smoking
• Secondhand Smoke
• Why Smoking is Hard to Quit
• Methods of Smoking Cessations
• Cold Turkey
• Drug Therapies
• Other Interventions
• Benefits of Quitting Smoking

2. World Smoking Statistics

3. Product Overview

• Smoking Cessation Aids Defined
• Nicotine Gum
• Factors to Consider
• Effectiveness of Nicotine Gum
• Nicotine Patch
• Factors to Consider
• Nicotine Lozenges & Tablets
• Factors to Consider
• Other Smoking Cessation Aids
• Nicotine Inhaler
• Factors to Consider
• Nicotine Nasal Spray
• Factors to Consider
• Non-Nicotine Based Medications

4. Trends and Issues

• Inundate Anti-Smoking Vaccines Kindles Underdeveloped Prescription Market
• Strict Regulations Deter Smoking Cessation Aids
• Growing Anti Smoking Campaigns
• Health Concerns
• Corporations Initiate for Smoke Free Work Environment
• Television Advertisements - Most Effective Media for Smoking Cessation
• Public Awareness through Internet
• Rising Prices of Tobacco - A Key Strategy for Quitting Smoking

5. Product Innovations/Introductions

• Acomplia to Enter Smoking Cessation Market
• Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US Market
• Nicodrops Unveils New Lozenge for Smoking Cessation
• Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan
• Glaxo Unveils First Anti-Smoking Medicine in India

6. Recent Industry Activity

• Pfizer Japan to Roll Out Champix Anti-Smoking Drug
• Inverness Medical Innovations Pockets Bio-Stat Healthcare Group
• Novartis New Smoking Cessation Aids Gets FDA' s Approval
• Johnson & Johnson Concludes Take Over of Pfizer Consumer Healthcare
• Pfizer Receives FDA Approval for Smoking Cessation Medicine Chantix(tm)
• Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum
• Pfizer Receives Chinese Approval for Clinical Trials on Smoking Cessation Aid
• Pfizer Receives EC Approval for New Varenicline
• Formation of Sanofi-Aventis
• AXIA Health Management Acquires Smoking Cessation Website
• Nicodrops Receives EC Approval for Smoking Cessation Aid
• Nabi Unveils Successful Phase II Results for Smoking Cessation Vaccine
• FDA Grants Approval for High Strength Bupropion
• Watson Pharmaceuticals Receives Rights to Market Zyban(r)
• Pfizer Merges with Pharmacia
• FDA Approves Anti-Smoking Medication for OTC Sales
• GSK and Taisho to Develop Anti-Smoking Medication
• Johnson & Johnson Acquires Alza

7. Focus on Select Global Players

• GlaxoSmithKline Plc (UK)
• Johnson & Johnson Inc. (USA)
• Novartis Consumer Healthcare Inc. (USA)
• Perrigo Company (USA)
• Pfizer Inc. (USA)

8. Global Market Perspective

• Table 6: World Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region - US, Canada, Europe and Rest of World Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 7: World Long Term Projections for Smoking Cessation Aids by Geographic Region - US, Canada, Europe and Rest of World Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 8: World 10-Year Perspective for Smoking Cessation Aids by Geographic Region - Percentage Break down of Dollar Sales for US, Canada, Europe and Rest of the World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Outlook
  • Cigarette Smoking Decline Stagnates in the US
  • Smoking Women are at High Risk
  • Tobacco Companies Spend Big on Advertising
  • NRT - A Peer into the Past
  • Popular NRT Brands in the US Market
  • Key Statistics:
  • Table 9: Top 4 Nicotine Chewing Gum Brands in the US: Breakdown of Dollar Sales Through Supermarkets, Drug Stores & Discount Stores for the Year Ended November 2007 (In US$ 000)
  • Table 10: US Market for Smoking Cessation Products: Percentage Share Breakdown of Value and Volume Sales by Product Category - Gum, Patch, Tablets, and Others (incl. Mouth Spray, Filters) for the Year Ended November 2007 (includes corresponding Graph/Chart)
  • Table 11: Leading NRT Brands in the US Market by Product Type in 2005: Sales in US$ Millions for Nicorette, Nicoderm CQ, Commit and Other Brands & Private Labels (includes corresponding Graph/Chart)
  • Product Launches/Developments
  • Strategic Corporate Developments
  • Key Players
• B. Market Analytics
  • Table 12: US Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 13: US Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 14: US 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 15: Canadian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 16: Canadian Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 17: Canadian 10-Year Perspective for Smoking Cessation aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Europe

• A. Market Analysis
  • Outlook
  • Strategic Corporate Developments
  • Key Players
• B. Market Analytics
  • Table 18: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region - France, Germany, UK, Italy, Spain & Rest of Europe Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 19: European Long Term Projections for Smoking Cessation Aids by Geographic Region - France, Germany, UK, Italy, Spain & Rest of Europe Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 20: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 21: European Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 22: European 10-Year Perspective for Smoking Cessation Aids by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 23: European 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3a. France

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 24: French Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 25: French Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 26: French 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

3b. Germany

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 27: German Recent Past, Current & Future Analysis for Smoking Cessation aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 28: German Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 29: German 10-Year Perspective for Smoking Cessation aids by Product Segment - Percentage Breakdown of Value Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets for 2003, 2008 and 2012 (includes corresponding Graph/Chart)

3c. The United Kingdom

• A. Market Analysis
  • Outlook
  • Table 30: Leading OTC-NRT Brands by Company in the UK in 2005: Percentage Breakdown of Value Sales for Nicorette, Niquitin CQ, Nicotinell and Others (includes corresponding Graph/Chart)
  • Table 31: NRT Advertisement Expenditure by Leading Companies in the UK in 2005: Percentage Breakdown for Pfizer, GlaxoSmithKline, Novartis and Others (includes corresponding Graph/Chart)
• B. Market Analytics
  • Table 32: UK Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 33: UK Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 34: UK 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003,2008 and 2012 (includes corresponding Graph/Chart)

3d. Italy

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 35: Italian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges and Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 36: Italian Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 37: Italian 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

3e. Spain

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 38: Spanish Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 39: Spanish Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 40: Spanish 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

3f. Rest of Europe

• A. Market Analysis
  • Outlook
• B. Market Analytics
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 42: Rest of Europe Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 43: Rest of Europe 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

4. Rest of World

• A. Market Analysis
  • Outlook
  • Smoking Statistics in China
  • Barriers to Promote Smoking Cessation in the Developing World
  • Economic Factors
  • Inadequate Policies to Support Cessation
  • Low Perception of Risk among Public and Policy Makers
  • Poor Healthcare Systems and Infrastructure
  • Lack of Technology
  • Strategic Corporate Developments
  • Product Launches
• B. Market Analytics
  • Table 44: Rest of World Recent Past, Current & Future Analysis for Smoking Cessation Aids - Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 45: Rest of World Long Term Projections for Smoking Cessation Aids - Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE